Huang; Audris
Patent Applications and Registrations
Patent applications and USPTO patent grants for Huang; Audris.The latest application filed is for "radioligands for imaging the id01 enzyme".
Company Profile
9.28.34
- Huang; Audris - New Hope PA
- Huang; Audris - Princeton NJ
- Huang; Audris - Irvine CA
Patent Activity
| Patent | Date |
|---|---|
| Radioligands For Imaging The Id01 Enzyme App 20220305144 - Donnelly; David J. ; et al. | 2022-09-29 |
| Cyclic dinucleotides as anticancer agents Grant 11,427,610 - Fink , et al. August 30, 2 | 2022-08-30 |
| Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Grant 11,337,970 - Cherney , et al. May 24, 2 | 2022-05-24 |
| Inhibitors Of Indoleamine 2,3-dioxygenase And Methods Of Their Use App 20210290613 - CHERNEY; Emily Charlotte ; et al. | 2021-09-23 |
| Cyclic Dinucleotides As Anticancer Agents App 20210253624 - FINK; Brian E. ; et al. | 2021-08-19 |
| Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Grant 11,066,392 - Balog , et al. July 20, 2 | 2021-07-20 |
| Compounds Useful As Inhibitors Of Helios Protein App 20210147383 - DEGNAN; Andrew P. ; et al. | 2021-05-20 |
| Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Grant 10,633,342 - Cherney , et al. | 2020-04-28 |
| Inhibitors Of Indoleamine 2,3-dioxygenase And Methods Of Their Use App 20200095231 - BALOG; James Aaron ; et al. | 2020-03-26 |
| Immunoregulatory agents Grant 10,533,014 - Beck , et al. Ja | 2020-01-14 |
| Radioligands For Imaging The Ido1 Enzyme App 20190282714 - Donnelly; David J. ; et al. | 2019-09-19 |
| Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer Grant 10,399,933 - Balog , et al. Sep | 2019-09-03 |
| Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer Grant 10,399,932 - Balog , et al. Sep | 2019-09-03 |
| Inhibitors Of Indoleamine 2,3-dioxygenase And Methods Of Their Use App 20190135758 - CHERNEY; Emily Charlotte ; et al. | 2019-05-09 |
| Immunoregulatory agents Grant 10,206,893 - Beck , et al. Feb | 2019-02-19 |
| Immunoregulatory Agents App 20190002472 - Beck; Hilary Plake ; et al. | 2019-01-03 |
| IDO inhibitors Grant 10,167,254 - Balog , et al. J | 2019-01-01 |
| Immunoregulatory Agents App 20180325889 - BECK; Hilary Plake ; et al. | 2018-11-15 |
| Immunoregulatory agents Grant 10,106,546 - Beck , et al. October 23, 2 | 2018-10-23 |
| Immunoregulatory Agents App 20180282281 - BECK; Hilary Plake ; et al. | 2018-10-04 |
| Inhibitors Of Indoleamine-2,3-dioxygenase For The Treatment Of Cancer App 20180079712 - Balog; James Aaron ; et al. | 2018-03-22 |
| Inhibitors Of Indoleamine-2,3-dioxygenase For The Treatment Of Cancer App 20180072660 - Balog; James Aaron ; et al. | 2018-03-15 |
| IDO inhibitors Grant 9,895,330 - Markwalder , et al. February 20, 2 | 2018-02-20 |
| IDO inhibitors Grant 9,790,169 - Balog , et al. October 17, 2 | 2017-10-17 |
| IDO inhibitors Grant 9,765,018 - Markwalder , et al. September 19, 2 | 2017-09-19 |
| IDO inhibitors Grant 9,758,492 - Markwalder , et al. September 12, 2 | 2017-09-12 |
| Ido Inhibitors App 20170231999 - Balog; James Aaron ; et al. | 2017-08-17 |
| Immunoregulatory Agents App 20170197973 - Beck; Hilary Plake ; et al. | 2017-07-13 |
| Inhibitors of indoleamine 2,3-dioxygenase (IDO) Grant 9,675,571 - Balog , et al. June 13, 2 | 2017-06-13 |
| Immunoregulatory Agents App 20170143649 - Beck; Hilary Plake ; et al. | 2017-05-25 |
| Immunoregulatory agents Grant 9,643,972 - Beck , et al. May 9, 2 | 2017-05-09 |
| IDO inhibitors Grant 9,624,188 - Balog , et al. April 18, 2 | 2017-04-18 |
| Immunoregulatory agents Grant 9,598,422 - Beck , et al. March 21, 2 | 2017-03-21 |
| Substituted bicyclic heteroaryl compounds Grant 9,598,436 - Balog , et al. March 21, 2 | 2017-03-21 |
| Ido Inhibitors App 20160289171 - Balog; James Aaron ; et al. | 2016-10-06 |
| Ido Inhibitors App 20160200674 - Markwalder; Jay A. ; et al. | 2016-07-14 |
| Ido Inhibitors App 20160143870 - Markwalder; Jay A ; et al. | 2016-05-26 |
| Immunoregulatory Agents App 20160137653 - Beck; Hilary Plake ; et al. | 2016-05-19 |
| Immunoregulatory Agents App 20160137652 - Beck; Hilary Plake ; et al. | 2016-05-19 |
| Ido Inhibitors App 20160137595 - Markwalder; Jay A. ; et al. | 2016-05-19 |
| Substituted Bicyclic Heteroaryl Compounds App 20160096847 - Balog; James Aaron ; et al. | 2016-04-07 |
| Ido Inhibitors App 20160060237 - Balog; James Aaron ; et al. | 2016-03-03 |
| Inhibitors Of Indoleamine 2,3-dioxygenase (ido) App 20160022619 - Balog; James Aaron ; et al. | 2016-01-28 |
| Substituted benzimidazole and imidazopyridine compounds useful as CYP17 modulators Grant 9,133,160 - Huang September 15, 2 | 2015-09-15 |
| Substituted bicyclic heteroaryl compounds Grant 8,969,586 - Balog , et al. March 3, 2 | 2015-03-03 |
| Sulfonamide compounds useful as CYP17 inhibitors Grant 8,916,553 - Austin , et al. December 23, 2 | 2014-12-23 |
| Sulfonamide Compounds Useful As Cyp17 Inhibitors App 20140148453 - Austin; Joel Francis ; et al. | 2014-05-29 |
| Azaindazole compounds Grant 8,673,922 - Velaparthi , et al. March 18, 2 | 2014-03-18 |
| Substituted Benzimidazole And Imidazopyridine Compounds Useful As Cyp17 Modulators App 20130310393 - Huang; Audris | 2013-11-21 |
| Azaindazole Compounds App 20130184254 - Velaparthi; Upender ; et al. | 2013-07-18 |
| Substituted quinolinecarboxamides as antiviral agents Grant 6,727,248 - Vaillancourt , et al. April 27, 2 | 2004-04-27 |
| Pyrroloquinolones as antiviral agents Grant 6,683,181 - Vaillancourt , et al. January 27, 2 | 2004-01-27 |
| Pyrroloquinolones as antiviral agents App 20030153561 - Vaillancourt, Valerie A. ; et al. | 2003-08-14 |
| Substituted quinolinecarboxamides as antiviral agents App 20030149035 - Vaillancourt, Valerie A. ; et al. | 2003-08-07 |
| Substituted quinolinecarboxamides as antiviral agents App 20020165253 - Vaillancourt, Valerie A. ; et al. | 2002-11-07 |
| Pyrroloquinolones as antiviral agents App 20020055636 - Vaillancourt, Valerie A. ; et al. | 2002-05-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 